GC1111

Clinical trials for GC1111 explained in plain language.

Never miss a new study

Get alerted when new GC1111 trials appear

Sign up with your email to follow new studies for GC1111, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Hunter syndrome drug hunterase passes Long-Term safety check in 30 patients

Disease control Completed

This study looked at the long-term safety of Hunterase, a drug for Hunter syndrome, in 30 patients who had already completed a previous study or used the drug for over 6 months. The main goal was to check for side effects and changes in lab tests, physical exams, and heart activi…

Matched conditions: GC1111

Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control

Last updated May 26, 2026 12:02 UTC

GC1111

Get alerted when new GC1111 trials appear

Hunter syndrome drug hunterase passes Long-Term safety check in 30 patients